Goodbye CPAP? New sleep apnea pill cuts breathing events by 44%
A once-nightly pill cut breathing interruptions by about 44% in a major phase 3 sleep apnea trial, while improving oxygen levels and disease severity. By strengthening the muscles that keep the airway open during sleep, AD109 could offer a new option for people unable to tolerate CPAP.
BlogZone shows headlines and summaries from public news feeds. The full story is published by ScienceDaily Health.
Read the full story at ScienceDaily Health →Enjoyed this?
Get more stories like this — and write your own — in the BlogZone app.

